期刊文献+

血清胱抑素C、尿微量白蛋白在高血压早期肾损害中的诊断价值 被引量:5

The Diagnostic Value of Serum Cystatin C and Microalbuminuria in Early Kidney Injury among Hypertensive
下载PDF
导出
摘要 目的探讨血清胱抑素C(Cys C)、24h尿微量白蛋白(24h MAU)对高血压早期肾功能损害的诊断价值。方法收集高血压患者234例,用同位素肾图检查作为金标准测定肾小球滤过率(GFR),按照GFR数值分成三组:肾功能无损害组、肾功能受损代偿组、肾功能受损失代偿组,同时测定每组血清Cys C、24h MAU、血肌酐及尿素氮,并分别计算每个指标在诊断高血压早期肾损害的灵敏度、特异度。结果随着GFR下降,血清Cys C、24h MAU、血肌酐及尿素氮均值逐渐升高(P<0.01)。将肾功能受损代偿组和肾功能受损失代偿组合并为肾功能受损组。肾功能无损害组79例患者血清中Cys C浓度异常者占3.80%,24h MAU浓度异常者占11.40%,血肌酐浓度异常者占0.00%,尿素氮异常者占0.00%;肾功能受损组155例患者血清中Cys C浓度异常者占45.16%,24h MAU浓度异常者占42.58%,血肌酐浓度异常者占18.06%,尿素氮异常者占18.71%。差异均有统计学意义(P<0.01)。四项指标诊断高血压早期肾功能损害的灵敏度分别为45.20%、42.60%、18.10%、18.70%,特异度分别为96.20%、88.60%、100.00%、100.00%,四项指标诊断高血压早期肾功能损害的ROC曲线下面积分别为0.76、0.66、0.63、0.69。结论血清Cys C、24h MAU是敏感且特异的反映肾小球滤过功能的指标,尤其是Cys C对高血压早期肾功能损害具有较高的诊断价值。 Objective To evaluate the clinical significance of serum Cystatin C( Cys C) and 24 h microalbuminuria( 24 h MAU) in diagnosis of early renal impaired patients with hypertension. Methods The study was performed on 234 hypertension patients. Checking for isotopes renal figure was used as the gold standard to measure the kidney estimated glomerular filtration rate( GFR),classifying the patients into three groups according to GFR numerical,isotope simultaneous determination of serum Cys C,24 h MAU,creatinine( Scr) and blood urea nitrogen( BUN) of each group,and calculating the sensitivity,specific degrees of each index in the diagnosis of early renal impairment in patients with hypertension,making a comparison to evaluate the value of serum Cys C,24 h MAU in hypertension patients in early renal damage diagnosis. Results The mean levels of Cys C,24 h MAU,Scr and BUN increased with the decrease of GFR( P 0. 01). Combining the second and third group as a renal damage group,and the first group as nondestructive group for renal function. The ratio of patients with abnormal Cys C,24 h MAU,Scr and BUN were 3. 8%,11. 4%,0. 0% and 0. 0% in the first group( n = 79),45. 16%,42. 58%,18. 06%and 18. 71% in the renal damage group( n = 155),respectively. The sensitivity of four indexes of diagnosing patients with primary hypertension and early renal impairment were 45. 2%,42. 6%,18. 1% and 18. 7%,the specificity were 96. 2%,88. 6%,100% and 100%. Area of ROC curves of four indexes of diagnosing patients with primary hypertension and early renal impairment were 0. 759,0. 655,0. 630 and 0. 689. Conclusions Serum Cys C,24 h MAU are sensitive and specific marks of renal injury. They are more significant than the other two indexes for renal impairment in patients with hypertension,of which the serum Cys C inhibition diagnosis is more worth than 24 h MAU.
出处 《心脑血管病防治》 2015年第5期366-368,374,共4页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 血清胱抑素C 24h尿微量白蛋白 高血压 肾功能损害 Cystatin C 24 h microalbuminuria Hypertension Renal impairment
  • 相关文献

参考文献7

二级参考文献23

  • 1余洪立.血清胱抑素C测定的方法学研究进展[J].广西医学,2004,26(3):366-368. 被引量:21
  • 2陈楠,陈佳韵.重视微量白蛋白尿的筛查与诊治[J].实用医院临床杂志,2005,2(1):17-19. 被引量:26
  • 3张丁丁,袁有才.糖尿病肾病患者血清胱抑素C水平的研究[J].广西医学,2005,27(5):638-639. 被引量:16
  • 4[1]Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (Cystatin C) amongst the cysteine proteinase inhibitors[J ]. Biochem Biophys Res Commun, 1984, 120:631.
  • 5[2]Sirmonsen O, Grubb A, Thysell H. The Blood serum concentration of cystatin C as a measure of glomerular filtration rate[J ]. Scand J Clin Lab Invest, 1985, 45:97.
  • 6[3]Tian S, Kusano E, Tabei K, et al. Cystatin C measurement and its practical use in patients with various renal diseases[J ]. Clin Nephrol,1997, 48:104.
  • 7[4]David JN, Hansa T, Robert GD, et al. Serum Cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine[J]. Kidney International, 1995, 47:312.
  • 8[5]Finney H, Newman DJ, Gruber W, et al. Initial evaluation of cystatin C measurement by particle enhanced immunonephelometry on the Behring nephelometer systems BNA,BNII[J ]. Clin Chem, 1997, 43:1016.
  • 9[6]Fanos V, Mussap M, Plebani M, et al. Cystatin C in paediatric nephrology. Present situation and prospects [J ]. Minerva-Pediatr,1999, 51:167.
  • 10[7]Jung K, Jung M. Cystatin C: a promising marker of glomerular filtration rate to replace creatinine[J]. Nephron, 1995, 70:370.

共引文献133

同被引文献50

  • 1李治国,周霞,张浩,齐丽荣.胱抑素C、同型半胱氨酸及N末端B型利钠肽原检测在老年慢性心力衰竭患者中的应用[J].中国老年学杂志,2014,34(11):3137-3138. 被引量:19
  • 2吕树铮.冠心病与糖尿病[J].医师进修杂志,2004,27(7):1-2. 被引量:23
  • 3中国高血压防治指南修订委员会.中国高血压防治指南2010.中华高血压杂志,201 1.
  • 4卫生部心血管病防治研究中心.中国心血管病报告,2012.北京:中国大百科全书出版社,2012:1-19.
  • 5Glynn LG, Reddan D, Newell J, et al. Chronic kidney disease and mortality and morbidity among patients with established car- diovascular disease: a West of Ireland community-based cohort study. Nephrol Dial Transplant, 2007,22 : 2586-2594.
  • 6Arulkumaran N, Diwakar R, Tahir Z, et al. Pulse pressure and progression of chronic kidney disease. J Nephrol,2010,23: 189- 193.
  • 7Cushman WC, Evans GW, Byington RP, et al. Effects of inten- sive blood-pressure control in type 2 diabetes mellitus. N Engl J Med, 2010,362 : 1575-1585.
  • 8Holman R. Metformin as first choice in oral diabetes treatment: the UKPDS experience. Journ Annu Diabetol Hotel Dieu, 2007,10: 13-20.
  • 9Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med, 2010,362 : 800-811.
  • 10Dilley J, Ganesan A, Deepa R. Association of AIC with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance. Diabetes Care,2007,30:1527- 1532.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部